RegisterLogin

PAI-2

CAT: 0209-100-425-L1000Size: 2x 500 µgDry Ice: NoHazardous: No
CAT#:0209-100-425-L1000Size:2x 500 µg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
PAI-2 is an inhibitory serpin expressed mainly in keratinocytes, activated monocytes, and placental trophoblasts. It exists predominantly as a 47 kDa nonglycosylated intracellular protein which can be induced to be secreted as 60 kDa glycoprotein. The glycosylated and unglycosylated forms of PAI-2 are equally effective as inhibitors of urokinase-type plasminogen activator (uPA), the only established physiological target of this serpin. PAI-2 has a unique ability to form dormant polymers spontaneously and reversibly under physiological conditions. The physiological relevance of this property, which is neither a consequence of any mutation in the PAI-2 gene nor associated with any known disorder, is still unclear. However, it appears that the formation of intracellular dormant polymers may be important for the controlled release of the inhibitor from PAI-2 producing cells. Plasma levels of PAI-2 are usually low or undetectable, except during pregnancy and in some forms of monocytic leukemia. Secretion of PAI-2 from the placenta normally occurs during the third trimester of pregnancy and accounts for the dramatic increase in PAI-2 levels (up to 250 ng/ml), which are maintained at these levels until postpartum, and then rapidly decline. In addition to its vital role in protecting the placenta from degradation by uPA and/or uPA-activated proteases, PAI-2 has been shown to be essential for the prevention of metastatic spread of neck, lung and breast cancers. The beneficial effect of PAI-2 seen in these studies is presumed to stem from its ability to inhibit uPA-dependent cell dissemination. PAI-2 has also been reported to inhibit keratinocyte proliferation, and to participate in the innate immune response during viral infection. Recombinant human PAI-2 is a 415-residue nonglycosylated protein.
Synonyms
Plasminogen Activator Inhibitor-2, Urokinase Inhibitor
NCBI Gene ID
5055
UniProt
P05120
Accession Number
NP_002566.1
Accession Number mRNA
NM_002575.2
Chromosomal Location
18q21.3
Reactivity
Human
Cross Reactivity
Mouse
Sequence
MEDLCVANTL FALNLFKHLA KASPTQNLFL SPWSISSTMA MVYMGSRGST EDQMAKVLQF NEVGANAVTP MTPENFTSCG FMQQIQKGSY PDAILQAQAA DKIHSSFRSL SSAINASTGN YLLESVNKLF GEKSASFREE YIRLCQKYYS SEPQAVDFLE CAEEARKKIN SWVKTQTKGK IPNLLPEGSV DGDTRMVLVN AVYFKGKWKT PFEKKLNGLY PFRVNSAQRT PVQMMYLREK LNIGYIEDLK AQILELPYAG DVSMFLLLPD EIADVSTGLE LLESEITYDK LNKWTSKDKM AEDEVEVYIP QFKLEEHYEL RSILRSMGME DAFNKGRANF SGMSERNDLF LSEVFHQAMV DVNEEGTEAA AGTGGVMTGR TGHGGPQFVA DHPFLFLIMH KITNCILFFG RFSSP
Endotoxin
< 0.1 ng/µg of protein (< 1EU/µg)
Purity
> 95% by SDS-PAGE & HPLC analyses
Bioactivity
Determined by its inhibitory effect against single chain tPA induced cleavage of a chromogenic substrate in Imidazole Buffer at 37°C. Half maximal inhibition against 1.0 μg/ml of single chain tPA was obtained at a concentration of 1.0 μg/ml
Length
415
Form
Lyophilized
Molecular Weight
45.6 kDa
Host or Source
E. coli

Related Products

CatalogName
100-424-L500PAI-1
100-424-L1000PAI-1
100-424-L50PAI-1
100-424-L100PAI-1
100-424PAI-1
100-424SPAI-1
102-P246PAI-1
100-424-L250PAI-1
R60-021-L100SerpinE1 / PAI-1 Protein (hFc Tag)
R60-022-L100SerpinE1 / PAI-1 Protein (His Tag)

Alternative Products

CatalogName
403362-01PAI-2
526683-01PAI 2
327353-01PAI-2
MBS691745-01Human PAI-2
MBS9508980-01PAI-2 Antibody
AF5174-01PAI 2 Antibody
E18-5174-1PAI 2 Antibody
MBS8511805-01PAI 2 Antibody
MBS9601347-01PAI 2 Antibody
345170-01PAI-2 discontinued

Popular Products